Patient‐Reported Symptom and Symptom Clusters During Immune Checkpoint Inhibitor Therapy for Cancer Patients: A Cross‐Sectional Survey

ABSTRACT Background and Aims Cancer treatment management necessitates comprehensive symptom burden assessment, particularly with therapies like immune checkpoint inhibitors (ICIs), known for unique toxicities. While ICIs show promising outcomes, they also induce immune‐related adverse events (irAEs)...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Simeng Ren, Jingqi Yang, Hongkun Xu, Jiayue Jin, Shuo Wang, Baojin Han, Wenzheng Zhang, Yutong Lv, Jie Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-01-01
coleção:	Health Science Reports
Assuntos:	cancer patients immune checkpoint inhibitor therapy patient‐reported outcomes symptom clusters
Acesso em linha:	https://doi.org/10.1002/hsr2.71708
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!